|
MICHAEL E. MOY
|
|
Experience:
|
§ Eight years as a DCAG Partner and consultant to Industry and Government; Thirty years with the Drug Enforcement Administration (DEA) including ten years as Chief, Drug Operations Section, DEA Office of Diversion Control; Five years with U.S. Public Health Service
|
|
Areas of Expertise:
|
§ Domestic/international drug regulatory investigations
§ Domestic registration system
§ Controlled Substances Import/Export Act
§ Domestic/international drug criminal investigations
§ Domestic data systems used to monitor/track controlled substances manufactured and distributed in the U.S.
§ Online diversion detection/investigative program
|
|
Education:
|
BA, Sociology, Western Michigan University
|
|
KENNETH J. RONALD
|
|
Experience:
|
§ Eight years as a DCAG Partner and consultant to Industry and Government; Twenty nine years with the Drug Enforcement Administration (DEA) including Executive Assistant to the Deputy Assistant Administrator, Office of Diversion Control and Legislative Liaison, Office of Congressional Affairs
|
|
Areas of Expertise:
|
§ Compliance with the Controlled Substances Act and its regulations
§ DEA policy on drug and chemical control issues
§ Drafting legislation at the Federal and state level
§ The legislative process in Congress
§ DEA’s investigative program for drug and chemical control
§ International treaty requirements
|
|
Education:
|
JD, State University of N.Y. at Buffalo, School of
Law Admitted to New York State Bar
|
|
FRANK L. SAPIENZA
|
|
Experience:
|
§ Eight years as a DCAG Partner and consultant to Industry and Government; Thirty one years with the Drug Enforcement Administration (DEA) including Chief, Drug and Chemical Evaluation Section, DEA Office of Diversion Control and forensic scientist, DEA Laboratory
|
|
Areas of Expertise:
|
§ Domestic and international scheduling; assessment of abuse potential
§ Exemptions, analogues, anabolic steroids and precursors
§ Legitimate medical need and quotas
§ U.S. and international narcotic raw material issues
International treaty requirements, reports and policies
§ Drug diversion, trafficking and abuse data collection and analysis
§ DEA/FDA interactions for drug development
§ Domestic and international chemical control issues, including illicit drug syntheses, exemptions, mixtures, and listed chemical regulations
|
|
Education:
|
BS and MS, Chemistry, University of Pittsburgh
|
|
TERRANCE W. WOODWORTH
|
|
Experience:
|
|
|
Area of Expertise:
|
§ Strategic and public policy development and implementation for drug and chemical control, regulation and investigations
§ International investigations, liaison and policy development
§ U.S. and international narcotic raw material issues
§ International drug and chemical control treaty matters
§ Domestic federal drug and chemical legislation, regulations, policies, and systems
|
|
Education:
|
BA, Economics, Texas A & M University;
MS, Management and Administrative Sciences,
University of Texas
|
|
|
|
|
 |
|
|
 |
| |
|
Providing services for
established pharmaceutical and chemical
firms, governments, associations, and companies entering the controlled
drug or chemical business |
|
